Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | i15.NKG2D.zeta NK cells |
| Synonyms | |
| Therapy Description |
i15.NKG2D.zeta NK cells are primary natural killer (NK) cells engineered to express a chimeric receptor consisting of NKG2D linked to the the T-cell receptor zeta chain, which may lead to killing of myeloid-derived suppressor cells in the tumor microenvironment and enhanced CAR-T cell activity (PMID: 30651290). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| i15.NKG2D.zeta NK cells | i15.NKG2D.zeta-NK cells | i15.NKG2D.zeta NK cells are primary natural killer (NK) cells engineered to express a chimeric receptor consisting of NKG2D linked to the the T-cell receptor zeta chain, which may lead to killing of myeloid-derived suppressor cells in the tumor microenvironment and enhanced CAR-T cell activity (PMID: 30651290). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|